Systemic Oxidative Stress Score as a Predictor of Gastric Cancer Survival and Recurrence Risk - Trial NCT06337279
Access comprehensive clinical trial information for NCT06337279 through Pure Global AI's free database. This phase not specified trial is sponsored by Fujian Medical University and is currently Completed. The study focuses on Gastric Cancer. Target enrollment is 3820 participants.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.
Study Focus
Observational
Sponsor & Location
Fujian Medical University
Timeline & Enrollment
N/A
Dec 10, 2022
Mar 20, 2024
Primary Outcome
5-year OS,5-year DFS
Summary
The Systemic Oxidative Stress Score (SOSS) , a comprehensive score reflecting the oxidative
 stress conditions in the microenvironment, can independently and effectively predict tumor
 burden and long-term prognosis in GC patients. Nomograms based on SOSS provide a potential
 and promising model for risk stratification and guiding the implementation of treatment
 decisions.
ICD-10 Classifications
Data Source
ClinicalTrials.gov
NCT06337279
Non-Device Trial